Intel Corporation [INTC]
Spot $86.24 (2026-07-28 close; $81.92 intraday 2026-07-29). Shares 5,043m. Market cap $434.9bn. Net debt $20,810m. EV $455.7bn. EV/Sales 7.99x. EV/EBIT: not defined — TTM operating income is −$77m.
| Input | Value | Note |
|---|---|---|
| Beta vs SPY, 252 sessions | 2.69 | the stock rose 347% off its 52-week low; the beta is a property of that move |
| Realised volatility, 252d | 77.8% | |
| Risk-free / ERP | 4.2% / 5.5% | stated assumptions |
| Cost of equity | 19.0% | |
| Pre-tax cost of debt | 6.0% | stated assumption |
| Tax rate | 10% | Intel's tax line is dominated by AMIC credits and valuation allowances; a low forward rate is used and its immateriality at a 90% equity weight is noted |
| Equity weight | 90% | |
| WACC | 17.6% |
A 17.6% WACC is aggressive and it is not the load-bearing input. §4 runs the full WACC sensitivity: at 9.0% — a generous normalisation implying Intel's cost of capital collapses back to mega-cap levels — the answer still fails. The conclusion is robust to the discount rate, which is stated explicitly so that the high beta cannot be blamed for it.
The brief instructs: "If terminal margin is underivable from INTC's own history, declare it UNIDENTIFIED rather than borrowing a peer's." It is underivable. Here is the record.
| Fiscal year | Revenue | Operating income | Operating margin |
|---|---|---|---|
| FY2021 | $79,024m | $19,456m | +24.6% |
| FY2022 | $63,054m | $2,334m | +3.7% |
| FY2023 | $54,228m | $93m | +0.2% |
| FY2024 | $53,101m | $(11,678)m | −22.0% |
| FY2025 | $52,853m | $(2,214)m | −4.2% |
| TTM to 2026-06-27 | $57,032m | $(77)m | −0.1% |
| Q2 2026 (quarter) | $16,128m | $1,796m | +11.1% |
Span: 46.6 percentage points. Mean −0.6%. Standard deviation ~15pp on five observations. There is no central tendency to estimate and no trend to extrapolate — the series is a step function around a structural break.
Three independent reasons the margin cannot be identified from outside:
Consequence for method. Because the input is unidentified, it becomes the output. The
implied-path test is run solving for the terminal margin — which is exactly what
reverse_dcf.py --solve terminal_margin exists for, and it removes the one parameter nobody can
observe from the assumption set.
Rejected: the screen's 9.1% "industry median of mature profitable peers." Intel is not a mature profitable peer of anything; its own record spans a range four times wider than the substituted value.
Intel's own multiple history is not usable as an anchor, and this is the honest reading rather than a convenient one:
| min | p10 | p25 | median | p75 | p90 | max | now | percentile | |
|---|---|---|---|---|---|---|---|---|---|
| EV/Sales, 6y (1,508 sessions from 2020-07-27) | 1.47x | 1.91x | 2.18x | 2.99x | 4.02x | 4.59x | 13.80x | 7.99x | 96th |
| EV/Sales, trailing 3y | — | — | 1.99x | 2.50x | 3.31x | — | — | 7.99x | 91st |
| EV/EBIT | not interpretable — TTM EBIT ≈ 0 | ||||||||
| P/E (trailing) | not interpretable — TTM EPS negative |
Three regimes in six years: a profitable near-monopolist (2020–21, EV/Sales 3–4x); a
collapse (2022–24, 1.5–3x); a government recapitalisation and AI re-rating (2025–26, 2.5 → 8.0x).
valuation.md is explicit that a history spanning a regime change should be declared unusable rather
than averaged. Declared.
Growth-matched comparator set, and why it too is imperfect. Two brackets were built from the 3,980-name universe, both restricted to SIC division 36 (electronic components / semiconductors) and market cap >$5bn:
| Bracket | n | Set growth range | Set op margin (median) | EV/EBIT p25 / median / p75 |
|---|---|---|---|---|
| A: growth 0–10% | 18 | 0.1% – 8.7% | 13.9% | 17.1x / 28.1x / 46.1x |
| B: growth 15–30% | 12 | 15.0% – 27.5% | 22.5% | 25.2x / 31.1x / 50.8x |
Largest members, bracket A: MU (7%, 38x), AMAT (3%, 45x), QCOM (0%, 14x), MSI (9%, 27x). Bracket B: AVGO (24%, 62x), APH (22%, 26x), VRT (22%, 54x), MPWR (16%, 80x).
Both brackets fail the strict test in the same way: neither brackets Intel's exit-year growth, because Intel's exit-year growth is itself not estimable (five-year CAGR −5.7%, latest quarter +25.4%). The two are presented to show the range is not identified, not to pick one. 28.1x (bracket A median) is used as the reference and 11.9x to 50.8x is carried through the sensitivity, which spans both brackets end to end.
assets/reverse_dcf.py, solving for terminal EBIT margin.
Terminal value is 100% of EV in this instrument, so the reverse DCF is the primary output.
Held fixed and named: revenue CAGR (varied across the grid); exit multiple (varied); WACC 17.6%; horizon 5 years; TTM revenue $57,032m; EV $455,714m (7.99x TTM revenue).
| Required terminal EBIT margin (10% CAGR, 28.1x) | 39.7% |
| Intel's best annual operating margin in the last decade (FY2021) | 24.6% |
| Margin: demonstrated maximum − required | −15.1pp |
| Intel's TTM operating margin | −0.1% |
| Intel's best-ever quarterly operating margin in this cycle (Q2 2026) | +11.1% |
| Intel Products segment margin, Q2 2026 (the most favourable figure in the file) | 31.8% |
Even Intel Products in isolation — a hypothetical fabless Intel with no Foundry and no corporate unallocated costs — earns 31.8%, which is 7.9 points BELOW what the price requires of the whole company.
| Revenue CAGR held at ↓ / exit multiple → | 11.9x | 17.1x | 25.2x | 28.1x | 31.1x | 46.1x | 50.8x |
|---|---|---|---|---|---|---|---|
| 5% | no soln | 82.3% | 55.9% | 50.1% | 45.3% | 30.5% | 27.7% |
| 10% | no soln | 65.2% | 44.3% | 39.7% | 35.9% | 24.2% | 22.0% |
| 15% | 75.1% | 52.2% | 35.5% | 31.8% | 28.7% | 19.4% | 17.6% |
| 20% | 60.7% | 42.2% | 28.7% | 25.7% | 23.2% | 15.7% | 14.2% |
The requirement only falls inside Intel's historical range (≤24.6%) in the bottom-right corner: a ≥20% five-year revenue CAGR combined with an exit multiple at or above 46.1x, the 75th percentile of a comparator set that does not bracket Intel's growth. Against a five-year demonstrated revenue CAGR of −5.7%.
Holding the terminal margin at Intel's best-ever 24.6% and solving for revenue CAGR:
| Exit multiple | 11.9x | 17.1x | 25.2x | 28.1x | 31.1x | 46.1x | 50.8x |
|---|---|---|---|---|---|---|---|
| Required revenue CAGR | 43.8% | 33.7% | 23.7% | 21.1% | 18.6% | 9.6% | 7.5% |
| Basis | Intel's demonstrated growth | Required (28.1x) | Margin |
|---|---|---|---|
| Latest-quarter run-rate (Q2 2026, +25.4%) | +25.4% | 21.1% | +4.3pp |
| Q3 2026 company guidance (midpoint $16.3bn) | +19.4% | 21.1% | −1.7pp |
| 5-year revenue CAGR (FY2021→TTM) | −5.7% | 21.1% | −26.8pp |
| 3-year revenue CAGR (FY2023→TTM) | +1.7% | 21.1% | −19.4pp |
This is the honest and uncomfortable part: on the run-rate alone the growth requirement is met by 4.3pp. It is reported rather than suppressed.
The reason is jointness, and it is stated as the operative logic rather than as a slogan:
Stated margin for the strategy to rank on: −15.1pp (demonstrated maximum operating margin minus the margin required at a 10% CAGR and a 28.1x exit).
Implied multiple compression: not statable in the usual form, because Intel has no current EV/EBIT. On EV/Sales the price today is 7.99x against an own six-year median of 2.99x — the implied requirement is that Intel sustain a 96th-percentile multiple, not compress to one.
| WACC | 9.0% | 10.0% | 12.0% | 14.0% | 17.6% |
|---|---|---|---|---|---|
| Required terminal EBIT margin | 27.2% | 28.4% | 31.1% | 34.0% | 39.7% |
At a 9.0% WACC the requirement is still 27.2% — above Intel's best-ever 24.6%. The FAIL does not depend on the 17.6% discount rate.
valuation.md: "If the history is too short or spans a regime change, declare it UNIDENTIFIED
rather than substituting a peer median."
Intel fails three separate preconditions for a 12-month target:
Declared UNIDENTIFIED. What is reported instead is the bound, because the bound is the useful output. NTM revenue is taken as ~$67bn (Q3 guided midpoint $16.3bn, held roughly flat-to-up through Q2 2027 — an extrapolation, labelled as one), net debt $20,810m, shares 5,043m:
| EV/Sales applied | Percentile of own 6y range | Implied equity value | Per share | vs spot $86.24 |
|---|---|---|---|---|
| 13.80x | max | $903.8bn | $179 | +108% |
| 7.99x | 96th — today | $514.5bn | $102 | +18% |
| 4.59x | p90 | $286.7bn | $57 | −34% |
| 4.02x | p75 | $248.5bn | $49 | −43% |
| 2.99x | median | $179.5bn | $36 | −59% |
| 2.18x | p25 | $125.2bn | $25 | −71% |
A range of −71% to +108% is not a target. It is a demonstration that the multiple, not the earnings, determines the answer — which is the finding, and the reason a number is refused.
One anchored cross-check, on the only forward earnings figure Intel has published: annualising the guided Q3 non-GAAP EPS of $0.38 gives $1.52, a forward non-GAAP P/E of 56.7x, against Intel's own trailing-P/E 90th percentile of 17.9x and median of 9.0x. Even on the most flattering earnings measure available, the multiple is 3.2x the 90th percentile of its own history.
Primary named cause: Intel Foundry never wins a material external customer.
The evidence is not a projection, it is the current disclosure: external third-party foundry revenue was $293m in Q2 2026 and $467m in H1 2026, against an Intel Foundry segment operating loss of $2,089m in the quarter. If 18A and 14A do not convert — and the mention-frequency series shows Intel itself de-emphasising both by 60–84% over nine quarters (§Research 7) — then the $16.1bn of subsidised gross PP&E and the ~$105bn net PP&E support only internal demand, the transfer-price subsidy from Products to Foundry persists, and the consolidated margin stays in the 0–12% band it has occupied since 2022 rather than returning to 24.6%.
Quantified on Intel's own multiple distribution, NTM revenue $67bn:
| Scenario | EV/Sales | Per share | vs spot |
|---|---|---|---|
| Foundry converts; multiple holds at today's 96th percentile | 7.99x | $102 | +18% |
| Foundry does not convert; multiple reverts to own six-year median | 2.99x | $36 | −59% |
| Foundry does not convert and capex guidance rises further; multiple to own p25 | 2.18x | $25 | −71% |
Base named downside: −57% to −59%. Probability: 35% (judgement, logged for Brier scoring).
Is it a going-concern case? No, and it must be argued rather than asserted. Liquid assets $29.7bn; H1 2026 free cash flow positive $1.9bn; Q2 operating cash flow $7.0bn; the US government is now an equity holder with 143m escrowed shares and 241m warrants, which is a strong (if uncomfortable) statement about political willingness to support the balance sheet; and the AMIC credit rate was just raised to 35%. This is a permanent-impairment-of-value case, not a solvency case.
Second named downside, mechanical and specific to this name: the escrow derivative liability is marked to Intel's own share price. A further rally increases the reported GAAP loss. It is not a driver of permanent loss, but it is why any screen, index rule, rating methodology or covenant that keys off GAAP earnings will read Intel's improvement as deterioration — and it is the reason no GAAP-earnings multiple appears anywhere in this memo.
Third, and it cuts the other way — the strongest contrary fact, stated fairly. Q2 2026 was, in the CEO's words, "our strongest revenue growth in more than fifteen years." Gross margin +12.9pp, operating margin +35.8pp, DCAI +59% with segment margin 16.1% → 39.5%, free cash flow positive for the first time since 2021, and non-GAAP EPS +$0.42 against −$0.10. If the operating turn continues at this rate the Valuation FAIL becomes a timing question rather than a structural one, and the Quality Criteria PASS is the record of that. What the price requires is nevertheless not what the business has ever delivered, and that is the Criteria's question.
| Trigger | Direction | Where it shows up |
|---|---|---|
| External foundry revenue exceeds ~$1bn in a quarter | strongly positive — it would begin to identify the terminal margin | 10-Q segment note, the "third-party foundry and assembly and test revenues" sentence |
| A named external 18A/14A customer with committed volume | strongly positive | 8-K or release |
| Two consecutive quarters of consolidated operating margin above 15% | positive; would start to make the margin identifiable | quarterly release |
| Capex guided above ~$20bn for 2027 | negative | 10-K/10-Q, CFO commentary |
| Further collapse in cash grant receipts (H1 2026 already −83%) | negative | investing cash flow, "Proceeds from capital-related government incentives" |
| The Delaware derivative suit invalidates the US Government Agreement | unquantifiable — would remove the $15.6bn derivative and the 241m warrants but also the funding | litigation note |
| Intel discloses a Foundry/Products transfer-pricing basis | would make the terminal margin identifiable for the first time | segment note |